Karo Pharma AB buy Raymond James
Start price
16.01.25
/
50%
€5.44
Target price
16.01.26
€49.43
Performance (%)
-
End price
17.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karo Pharma AB | - | - | - |
| iShares Core DAX® | -1,09 % | 0,20 % | 2,09 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % | 29,25 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % | 54,33 % |
| iShares S&P 500 | -0,20 % | 1,77 % | 23,58 % |
Comments by Raymond_James for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock, up previously from $46.00.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten